Menu

Blog

Apr 29, 2022

YouthBio CEO: The time is right to develop epigenetic reprogramming therapies

Posted by in categories: biotech/medical, genetics, life extension

Earlier this month, we brought you the news that epigenetic reprogramming startup YouthBio Therapeutics had emerged from stealth. The company shed some light on its plans to develop epigenetic reprogramming therapies for age-related diseases by rejuvenating certain cells in our bodies. YouthBio aims to achieve this rejuvenation by developing gene therapies that enable partial cellular reprogramming – an area of longevity science that is now attracting significant commercial interest.

Longevity. Technology: Cellular reprogramming refers to the process of returning adult cells to a “pluripotent” state: blank, embryonic-like cells that can become any cell in the body. This reprogramming can be achieved using techniques based on the discovery of Yamanaka factors.

1

Comment so far


  1. Wtf?! You people need to have a COME TO JESUS moment. NOW! Satanists freaks of society!

Leave a reply